Both albiglutide and dulaglutide are GLP-1 analogues with an alanine-to-glycine substitution at position 8, rendering the peptides resistant to DPP-4 enzymatic activity [ Figure 2 and Table 1 ]
The review further distinguishes between established outcome benefits (CVD, CKD, and OSA) and conditions still under investigation (neurodegeneration, arthritis, and some liver endpoints)
These innovations aim to improve treatment adherence, reduce reliance on injectable delivery systems and broaden therapeutic accessibility for individuals managing obesity and type 2 diabetes
Creating a bedtime routine and a clear sleep schedule makes all the difference, so its worth sitting down and thinking about what that looks like for you
Topiramate is used for weight loss and is also used off-label and endorsed by the American Psychiatric Association as a second-line treatment for AUD [25]
Delivering GLP-1 medications through the skin isnt currently feasible, making patches an ineffective delivery method for this class of drugs